| 期刊論文| 1. | Woods, S. W.(2003)。Chlorpromazine equivalent doses for the newer atypical antipsychotics。Journal of Clinical Psychiatry，64，663-667。   | | 2. | Tor, Phern-Chern、Ng, Tze Pin、Yong, Kian-Hui(2011)。Adjunctive benzodiazepine treatment of hospitalized schizophrenia patients in Asia from 2001 to 2008。International Journal of Neuropsychopharmacology，14，735-745。 | | 3. | Xiang, Y.-T.、Wang, C.-Y.、Si, T.-M.(2011)。Use of anticholinergic drugs in patients with schizophrenia in Asia from 2001 to 2009。Pharmacopsychiatry，44，114-118。 | | 4. | Xiang, Y.-T.、Dickerson, F.、Kreyenbuhl, J.(2012)。Adjunctive mood stabilizer and benzodiazepine use in older Asian patients with schizophrenia, 2001-2009。Pharmacopsychiatry，45，217-222。 | | 5. | Xiang, Y.-T.、Dickerson, F.、Kreyenbuhl, J.(2012)。Common use of antipsychotic polypharmacy in older Asian patients with schizophrenia (2001-2009)。Journal of Clinical Psychopharmacology，32，809-813。 | | 6. | Xiang, Yu-Tao、Buchanan, Robert W.、Ungvari, Gabor S.(2013)。Use of clozapine in older Asian patients with schizophrenia between 2001 and 2009。PLoS One，8。 | | 7. | Hennekens, C. H.、Hennekens, A. R.、Hollar, D.、Casey, D. E.(2005)。Schizophrenia and increased risks of cardiovascular disease。American Heart Journal，150(6)，1115-1121。 | | 8. | Lieberman, J. A.、Stroup, T. S.、McEvoy, J. P.、Swartz, M. S.、Rosenheck, R. A.、Perkins, D. O.、Hsiao, J. K.(2005)。Effectiveness of antipsychotic drugs in patients with chronic schizophrenia。New England Journal of Medicine，353(12)，1209-1223。 | | 9. | Sim, Kang、Su, Alex、Fujii, Senta(2004)。Antipsychotic polypharmacy in patients with schizophrenia: a multicentre comparative study in East Asia。British Journal of Clinical Pharmacology，58，178-183。 | | 10. | Weich, S.、Pearce, H. L.、Croft, P.、Singh, S.、Crome, I.、Bashford, J.、Frisher, M.(2014)。Effect of anxiolytic and hypnotic drug prescriptions on mortality hazards: retrospective cohort study。British Medical Journal，348。 | | 11. | Kay, Stanley R.、Fiszbein, Abraham、Opler, Lewis A.(1987)。The Positive and Negative Syndrome Scale (PANSS) for schizophrenia。Schizophrenia Bulletin，13(2)，261-276。 | | 12. | Anstey, K. J.、von Sanden, C.、Luszcz, M. A.(2006)。An 8-year prospective study of the relationship between cognitive performance and falling in very old adults。Journal of the American Geriatrics Society，54，1169-1176。 | | 13. | Kane, J.、Honigfeld, G.、Singer, J.、Meltzer, H. Y.、Clozaril Collaborative Study Group(1988)。Clozapine for the treatment-resistant schizophrenic: A double-blind comparison with chlorpromazine。Archives of General Psychiatry，45(9)，789-796。 | | 14. | Xiu, M. H.、Hui, L.、Dang, Y. F.(2009)。Decreased serum BDNF levels in chronic institutionalized schizophrenia on long-term treatment with typical and atypical antipsychotics。Progress in Neuro-Psychopharmacology and Biological Psychiatry，33，1508-1512。 | | 15. | Saha, Sukanta、Chant, David、Welham, Joy、McGrath, John(2005)。A systematic review of the prevalence of schizophrenia。PLoS Medicine，2(5)。 | | 16. | Faden, J.、Citrome, L.(2019)。Resistance is not futile: treatment-refractory schizophrenia: overview, evaluation and treatment。Expert Opinion on Pharmacotherapy，20，11-24。 | | 17. | Jäger, M.、Riedel, M.、Obermeier, M.(2010)。Time course of antipsychotic treatment response in schizophrenia: results from a naturalistic study in 280 patients。Schizophrenia Research，118，183-188。 | | 18. | Bhugra, D.(2006)。Severe mental illness across cultures。Acta Psychiatrica Scandinavica，113(Suppl.)，17-23。 | | 19. | Fenton, W. S.、McGlashan, T. H.、Victor, B. J.(1997)。Symptoms, subtype, and suicidality in patients with schizophrenia spectrum disorders。American Journal of Psychiatry，154，199-204。 | | 20. | Kohen, Izchak、Lester, Paula E.、Lam, Sum(2010)。Antipsychotic treatments for the elderly: efficacy and safety of aripiprazole。Neuropsychiatric Disease and Treatment，6，47-58。 | | 21. | Meyers, B. S.、Jeste, D. V.(2010)。Geriatric psychopharmacology: evolution of a discipline。Journal of Clinical Psychiatry，71，1416-1424。 | | 22. | Uchida, H.、Pollock, B. G.、Bies, R. R.(2009)。Predicting age-specific dosing of antipsychotics。Clinical Pharmacology & Therapeutics，86，360-362。 | | 23. | Wahlbeck, K.、Cheine, M.、Essali, M. A.(2000)。Clozapine versus typical neuroleptic medication for schizophrenia。Cochrane Database of Systematic Reviews，2000(2)。 | | 24. | Kane, John M.(1992)。Clinical efficacy of clozapine in treatment-refractory schizophrenia: an overview。British Journal of Psychiatry，17(Suppl.)，41-45。 | | 25. | Suzuki, T.、Uchida, H.、Takeuchi, H.(2009)。Augmentation of atypical antipsychotics with valproic acid: an open-label study for most difficult patients with schizophrenia。Human Psychopharmacology，24，628-638。 | | 26. | Remington, G.、Saha, A.、Chong, S.-A.(2005)。Augmentation strategies in clozapine-resistant schizophrenia。CNS Drugs，19，843-872。 | | 27. | Ganguly, R.、Kotzan, J. A.、Miller, L. S.、Kennedy, K.、Martin, B. C.(2004)。Prevalence, trends, and factors associated with antipsychotic polypharmacy among Medicaid-eligible schizophrenia patients, 1998-2000。Journal of Clinical Psychiatry，65，1377-1388。 | | 28. | Chen, Wen-Ching、Wang, Jung-Der、Lew-Ting, Chih-Yin(2007)。Workplace violence on workers caring for long-term institutionalized schizophrenic patients in Taiwan。Journal of Occupational Health，49，311-316。 | | 29. | Wu, B. Y.、Wu, B. J.、Lee, S. M.(2014)。Prevalence and associated factors of comorbid skin diseases in patients with schizophrenia: a clinical survey and national health database study。General Hospital Psychiatry，36，415-421。 | | 30. | Wang, San-Ping、Wang, Jung-Der、Chang, Jer-Hao(2020)。Symptomatic remission affects employment outcomes in schizophrenia patients。BMC Psychiatry，20。 | | 31. | Xu, Shi-Wei、Dong, Min、Zhang, Qinge(2020)。Clozapine prescription pattern in patients with schizophrenia in Asia: the REAP survey (2016)。Psychiatry Research，287。 | | 32. | Davidson, M.、Harvey, P. D.、Powchik, P.(1995)。Severity of symptoms in chronically institutionalized geriatric schizophrenic patients。American Journal of Psychiatry，152，197-207。 | | 33. | Nielsen, J.、Røge, R.、Schjerning, O.(2012)。Geographical and temporal variations in clozapine prescription for schizophrenia。European Neuropsychopharmacology，22，818-824。 | | 34. | Dong, M.、Zeng, L.-N.、Zhang, Q.(2019)。Prescription of antipsychotic and concomitant medications for adult Asian schizophrenia patients: findings of the 2016 Research on Asian Psychotropic Prescription Patterns (REAP) survey。Asian Journal of Psychiatry，45，74-80。 | | 35. | Citrome, L.、Levine, J.、Allingham, B.(2000)。Changes in use of valproate and other mood stabilizers for patients with schizophrenia from 1994 to 1998。Psychiatric Services，51，634-638。 | | 36. | Dong, M.、Zeng, L.-N.、Zhang, Q.(2019)。Antipsychotic polypharmacy in older adult Asian patients with schizophrenia: research on Asian Psychotropic Prescription Pattern。Journal of Geriatric Psychiatry and Neurology，32，304-311。 | | 37. | Yang, Shu-Yu、Chen, Lian-Yu、Najoan, Eunice、Kallivayalil, Roy Abraham、Viboonma, Kittisak、Jamaluddin, Ruzita、Javed, Afzal、Hoa, Duong Thi Quynh、Iida, Hitoshi、Sim, Kang、Swe, Thiha、He, Yan-Ling、Park, Yongchon、Ahmed, Helal Uddin、de Alwis, Angelo、Chiu, Helen Fung-Kum、Sartorius, Norman、Tan, Chay-Hoon、Chong, Mian-Yoon、Shinfuku, Naotaka、Lin, Shih-Ku(2018)。Polypharmacy and psychotropic drug loading in patients with schizophrenia in Asian countries: fourth survey of Research on Asian Prescription Patterns on antipsychotics。Psychiatry and Clinical Neurosciences，72(8)，572-579。 | | 38. | Chong, Mian-Yoon、Tan, Chay Hoon、Fujii, Senta、Yang, Shu-Yu、Ungvari, Gabor S.、Si, Tianmei、Chung, Eun Kee、Sim, Kang、Tsang, Hin-Yeung、Shinfuku, Naotaka(2004)。Antipsychotic drug prescription for schizophrenia in East Asia: rationale for change。Psychiatry and Clinical Neurosciences，58(1)，61-67。 | | 39. | Gören, J. L.、Meterko, M.、Williams, S.(2013)。Antipsychotic prescribing pathways, polypharmacy, and clozapine use in treatment of schizophrenia。Psychiatric Services，64，527-533。 | | 40. | Kreyenbuhl, J.、Valenstein, M.、McCarthy, J. F.(2006)。Long-term combination antipsychotic treatment in VA patients with schizophrenia。Schizophrenia Research，84，90-99。 | | 41. | Gallego, J. A.、Bonetti, J.、Zhang, J.(2012)。Prevalence and correlates of antipsychotic polypharmacy: a systematic review and meta-regression of global and regional trends from the 1970s to 2009。Schizophrenia Research，138，18-28。 | | 42. | Landi, F.、Dell'Aquila, G.、Collamati, A.(2014)。Anticholinergic drug use and negative outcomes among the frail elderly population living in a nursing home。Journal of the American Medical Directors Association，15，825-829。 | | 43. | Dauphinot, V.、Faure, R.、Omrani, S.(2014)。Exposure to anticholinergic and sedative drugs, risk of falls, and mortality: an elderly inpatient, multicenter cohort。Journal of Clinical Psychopharmacology，34，565-570。 | | 44. | Beuscart, J.-B.、Dupont, C.、Defebvre, M.-M.(2014)。Potentially inappropriate medications (PIMs) and anticholinergic levels in the elderly: a population based study in a French region。Archives of Gerontology and Geriatrics，59，630-635。 | | 45. | Cancelli, I.、Gigli, G. L.、Piani, A.(2008)。Drugs with anticholinergic properties as a risk factor for cognitive impairment in elderly people: a population-based study。Journal of Clinical Psychopharmacology，28，654-659。 | | 46. | Aizenberg, D.、Sigler, M.、Weizman, A.(2002)。Anticholinergic burden and the risk of falls among elderly psychiatric inpatients: a 4-year case-control study。International Psychogeriatrics，14，307-310。 | | 47. | Fassino, S.、Amianto, F.、Gastaldo, L.(2009)。Anger and functioning amongst inpatients with schizophrenia or schizoaffective disorder living in a therapeutic community。Psychiatry and Clinical Neurosciences，63，186-194。 | | 48. | Xiang, Y.-T.、Dickerson, F.、Kreyenbuhl, J.(2013)。Common use of anticholinergic medications in older patients with schizophrenia: findings of the Research on Asian Psychotropic Prescription Pattern (REAP) study, 2001-2009。International Journal of Geriatric Psychiatry，28，305-311。 | |